Brief: Alligator Bioscience Q1 Operating Loss Lowers To SEK 43.7 Mln
April 24 (Reuters) - Alligator Bioscience AB ATORX.ST: Q1 OPERATING LOSS SEK 43.7 MILLION VERSUS LOSS SEK 59.6 MILLION YEAR AGO Source text: ID:nMFN15Xf7k Further company coverage: ATORX.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue